Hill-Rom Holdings Inc. has acquired Mortara Instrument Inc for $330 million, the company announced.

The acquisition accelerates Hill-Rom’s revenue growth, is accretive to adjusted gross and operating margins, and is immediately accretive to Hill-Rom’s 2017 full-year adjusted earnings. Hill-Rom will provide updated revenue and earnings guidance during its fiscal second quarter earnings announcement.

Mortara’s innovative portfolio of diagnostic cardiology devices is designed to serve the full continuum of clinical care, from acute care to primary care and clinical research organizations. Mortara’s comprehensive range of products, operating under the Mortara, Quinton┬« and Burdick┬« brands, include resting electrocardiography, cardiac stress exercise, Holter monitoring, ambulatory blood pressure monitoring, and cardiac and pulmonary rehabilitation and multi-parameter patient monitoring.

Read more at www.prnewswire.com